Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 21, 2022 17:00 ET | Source: DSS, Inc.

DSS Announces Licensing of Impact BioMedical’s Linebacker Portfolio to ProPhase Labs

ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing...
July 13, 2022 08:00 ET | Source: DSS, Inc.

DSS Strengthens and Expands Board with Appointment of Two Independent Directors

ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing...
June 28, 2022 08:00 ET | Source: DSS, Inc.

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research...
June 07, 2022 07:00 ET | Source: DSS, Inc.

DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

HENRIETTA, N.Y., June 07, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically...
May 06, 2022 08:30 ET | Source: DSS, Inc.

DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

ROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets...
March 03, 2022 08:00 ET | Source: DSS, Inc.

Impact BioMedical’s Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization’s ISA Division

ROCHESTER, N.Y., March 03, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research...
February 28, 2022 17:15 ET | Source: DSS, Inc.

CORRECTION - DSS Announces Letter to Shareholders

ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by DSS, Inc. (NYSE American: DSS), please note that in paragraph fourteen, [With more...
February 28, 2022 08:00 ET | Source: DSS, Inc.

DSS Announces Letter to Shareholders

ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with ten operating business lines in diverse, high-growth...
February 22, 2022 17:00 ET | Source: DSS, Inc.

DSS to Present at Aegis Virtual Conference

ROCHESTER, N.Y., Feb. 22, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
January 25, 2022 16:30 ET | Source: DSS, Inc.

DSS Receives $17 Million Investment from Alset EHome International

ROCHESTER, N.Y., Jan. 25, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right